SBI Securities’s Co-Diagnostics CODX Stock Holding History

SBI Securities’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$150	Buy	140 +59	+73%	+$95	﹤0.01%	3484
2026 Q2	$251	Buy	81 +23	+40%	+$71	﹤0.01%	3259
2026 Q1	$108	Buy	58 +11	+23%	+$38	﹤0.01%	3383
2025 Q4	$236	Hold	47	–	–	﹤0.01%	3158
2025 Q3	$481	Hold	47	–	–	﹤0.01%	2984
2025 Q2	$391	Hold	47	–	–	﹤0.01%	3065
2025 Q1	$433	Buy	47 +7	+18%	+$134	﹤0.01%	2920
2024 Q4	$898	Buy	+40	New	+$1.26K	﹤0.01%	2659

SBI Securities's CODX Position: Q3 2026 in Review

SBI Securities increased its Co-Diagnostics (CODX) stake by 73% in Q3 2026, buying an estimated $95 and bringing the position to 140 shares worth $150. The position accounts for ﹤0.01% of the portfolio, ranked #3484.

SBI Securities first reported a position in CODX in Q4 2024 and has held it in 8 quarters since. The position peaked at $898 in Q4 2024. 1 fund tracked by Wall St. Rank holds CODX as of Q3 2026.

SBI Securities held 140 shares of Co-Diagnostics worth $150 as of Q3 2026.
SBI Securities bought 59 Co-Diagnostics shares in Q3 2026, an estimated $95.
Co-Diagnostics made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3484 holding.
SBI Securities first reported a position in Co-Diagnostics in Q4 2024 and has held it in 8 quarters since.
SBI Securities's Co-Diagnostics position peaked at $898 in Q4 2024.
1 fund tracked by Wall St. Rank held Co-Diagnostics as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.